Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
Sponsor: Sunnybrook Health Sciences Centre
A observational or N/A phase clinical study on Breast Cancer and Invasive Ductal Breast Carcinoma, this trial is ongoing. The trial is conducted by Sunnybrook Health Sciences Centre and has accumulated 7 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Oct 2024 — Present [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Dec 2021 — Jul 2024 [monthly]
Active Not Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2019 — Nov 2020 [monthly]
Active Not Recruiting
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sunnybrook Health Sciences Centre
For direct contact, visit the study record on ClinicalTrials.gov .